Clinical Trial Update: Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD) [Phase 1, Phase 2]

View source ↗

Summary

Exploratory safety study of ALD518 in steroid-refractory acute graft-versus-host disease (GVHD) across Phase 1/2, terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• ALD518

Snippet

Sponsor: CSL Behring | Conditions: Acute GvHD | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-02-17